Literature DB >> 19566789

Virological and clinical characteristics of delta hepatitis in Central Europe.

B Heidrich1, K Deterding, H L Tillmann, R Raupach, M P Manns, H Wedemeyer.   

Abstract

Hepatitis D virus (HDV) or delta hepatitis has mainly been studied in Asian and Mediterranean cohorts, but data on virological and clinical characteristics of HDV-infected Central and Northern European patients are limited. We investigated virological patterns, as well as biochemical and clinical features of liver disease in 258 HDV infected patients recruited over a period of 15 years at Hannover Medical School. Virological parameters were compared to 2083 anti-HDV negative hepatitis B surface antigen (HBsAg) positive individuals. In this cohort, (i) HDV infection was associated with both suppressed hepatitis B virus (HBV) and hepatitis C virus (HCV) replication, (ii) the suppression of HBV-DNA and HCV-RNA was not related to HDV-RNA replication, (iii) mean HBsAg levels did not significantly differ between HBV-monoinfected patients and individuals with delta hepatitis, (iv) HCV coinfection was rather frequent as about one third of our delta hepatitis patients tested anti-HCV positive, however, without being associated with more advanced liver disease, (v) delta hepatitis patients presented in a high frequency with an advanced stage of liver disease, and (vi) the course of delta hepatitis did not differ between Turkish-born, Eastern European (EE)-born and German-born patients. In summary, in this cohort of patients which is the largest so far Central European single centre group of delta hepatitis patients, we confirm the presence of frequently severe disease and describe novel virological profiles which require consideration in the management of this difficult to treat group of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566789     DOI: 10.1111/j.1365-2893.2009.01144.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  27 in total

1.  Current concept in the pathophysiology of hepatitis delta infection.

Authors:  Grazia Anna Niro; Antonina Smedile
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

2.  High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon.

Authors:  Yacouba Foupouapouognigni; Dominique Noah Noah; Michèle Tagni Sartre; Richard Njouom
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

3.  Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Authors:  Ingmar Mederacke; Birgit Bremer; Benjamin Heidrich; Janina Kirschner; Katja Deterding; Thomas Bock; Karsten Wursthorn; Michael P Manns; Heiner Wedemeyer
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

4.  Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study.

Authors:  Ségolène Brichler; Frédéric Le Gal; Fernando Neri-Pinto; Wael Mansour; Dominique Roulot; Syria Laperche; Emmanuel Gordien
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

5.  Hepatitis D Virus: A Call to Screening.

Authors:  Joseph Ahn; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

6.  Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification.

Authors:  Frédéric Le Gal; Samira Dziri; Athenaïs Gerber; Chakib Alloui; Zahia Ben Abdesselam; Dominique Roulot; Ségolène Brichler; Emmanuel Gordien
Journal:  J Clin Microbiol       Date:  2016-11-23       Impact factor: 5.948

Review 7.  Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Authors:  Florian A Lempp; Yi Ni; Stephan Urban
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

8.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

9.  Treatment options for hepatitis delta virus infection.

Authors:  Benjamin Heidrich; Michael P Manns; Heiner Wedemeyer
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 10.  Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.

Authors:  Heiner Wedemeyer; Michael P Manns
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.